داروسازی فارابی
دفارا | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 19,980 2.99
Close Price: 19,930
Cash Flow
AGM
Interim
2026/07/04 Fiscal Year 2026/03/2012 Month / Audited | 2026/06/17 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | 7.677 Trillion | 7.677 Trillion | |
Income Taxes Paid | -188 Billion | -188 Billion | |
Net Cash Flow from Operating Activities | 7.489 Trillion | 7.489 Trillion | |
Proceeds from Sale of Property, Plant and Equipment | 10.709 Billion | 10.709 Billion | |
Purchases of Property, Plant and Equipment | -116.714 Billion | -116.714 Billion | |
Purchases of Intangible Assets | -1.45 Billion | -1.45 Billion | |
Cash Paid to Acquire Long-Term Investments | -59 Million | -54 Million | |
Cash Received from Income on Other Investments | 8.353 Billion | 8.353 Billion | |
Net Cash Flow from Investing Activities | -108.361 Billion | -108.361 Billion | |
Net Cash Flow before Financing Activities | 7.381 Trillion | 7.381 Trillion | |
Cash Received from Borrowings | 7.39 Trillion | 8.634 Trillion | |
Repayments of Borrowings (Principal) | -7.176 Trillion | -7.176 Trillion | |
Interest Paid on Borrowings | -1.61 Trillion | -2.854 Trillion | |
Dividends Paid | -5.743 Trillion | -5.743 Trillion | |
Dividends Paid to Non-Controlling Interests | -1.55 Trillion | -1.55 Trillion | |
Net Cash Flow from Financing Activities | -7.139 Trillion | -7.139 Trillion | |
Net Increase (Decrease) in Cash | 242.479 Billion | 242.479 Billion | |
Cash at Beginning of Period | 479.833 Billion | 479.833 Billion | |
Effect of Exchange Rate Changes | 177.483 Billion | 177.483 Billion | |
Cash at End of Period | 899.795 Billion | 2.811 Trillion |